These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12161113)
1. L-Cysteine based N-type calcium channel blockers: structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takenobu Y; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem Lett; 2002 Sep; 12(17):2267-9. PubMed ID: 12161113 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity study of L-cysteine-based N-type calcium channel blockers: optimization of N- and C-terminal substituents. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem Lett; 2002 Mar; 12(6):915-8. PubMed ID: 11958993 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity study of L-amino acid-based N-type calcium channel blockers. Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M Bioorg Med Chem; 2003 Apr; 11(8):1901-13. PubMed ID: 12659776 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain. Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361 [TBL] [Abstract][Full Text] [Related]
13. Huwentoxin-XVI, an analgesic, highly reversible mammalian N-type calcium channel antagonist from Chinese tarantula Ornithoctonus huwena. Deng M; Luo X; Xiao Y; Sun Z; Jiang L; Liu Z; Zeng X; Chen H; Tang J; Zeng W; Songping Liang Neuropharmacology; 2014 Apr; 79():657-67. PubMed ID: 24467846 [TBL] [Abstract][Full Text] [Related]
14. Discovery and SAR of a novel series of 2,4,5,6-tetrahydrocyclopenta[c]pyrazoles as N-type calcium channel inhibitors. Winters MP; Subasinghe N; Wall M; Beck E; Brandt MR; Finley MF; Liu Y; Lubin ML; Neeper MP; Qin N; Flores CM; Sui Z Bioorg Med Chem Lett; 2014 May; 24(9):2057-61. PubMed ID: 24726803 [TBL] [Abstract][Full Text] [Related]
15. The discovery of [1-(4-dimethylamino-benzyl)-piperidin-4-yl]-[4-(3,3-dimethylbutyl)-phen yl]-(3-methyl-but-2-enyl)-amine, an N-type Ca+2 channel blocker with oral activity for analgesia. Hu LY; Ryder TR; Rafferty MF; Taylor CP; Feng MR; Kuo BS; Lotarski SM; Miljanich GP; Millerman E; Siebers KM; Szoke BG Bioorg Med Chem; 2000 Jun; 8(6):1203-12. PubMed ID: 10896101 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain. Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987 [TBL] [Abstract][Full Text] [Related]
17. Discovery and optimization of a novel series of pyrazolyltetrahydropyran N-type calcium channel (Ca Wall MJ; Subasinghe NL; Winters MP; Lubin ML; Finley MFA; Qin N; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3780-3783. PubMed ID: 30337231 [TBL] [Abstract][Full Text] [Related]
18. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence. Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913 [TBL] [Abstract][Full Text] [Related]
19. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker. Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438 [TBL] [Abstract][Full Text] [Related]